Achieve Life Sciences Inc.

NASDAQ: ACHVHealthcare / Biotechnology / -
1.86-0.0300-1.59%Vol 110 8561Y Perf -44.24%
Jul 22nd, 2019 16:00
BID1.86 ASK1.93
Open1.83 Previous Close1.89
Pre-Market- After-Trading-
 - -%  - -%
Target Price
10.67 
Analyst Rating
Strong Buy 1.00
Potencial %
473.66 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)13 
Earnings Rating
Neutral
Price Range Ratio 52wk %
19.48 
Earnings Date
14th Aug 2019

Today's Price Range

1.771.94

52wk Range

1.045.25

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-4.62%
1 Month
-19.83%
3 Months
-54.07%
6 Months
48.80%
1 Year
-44.24%
3 Years
-98.12%
5 Years
-99.45%
10 Years
-99.94%

Name / TickerPriceChg.Chg.%
ACHV1.86-0.0300-1.59
AAPL207.224.63002.29
GOOG1 138.077.97000.71
MSFT138.431.81001.32
XOM75.070.08000.11
WFC46.480.45000.98
JNJ128.64-1.6700-1.28
FB202.323.96002.00
GE10.210.17001.69
JPM114.270.73000.64
Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.88-
Q04 2018--0.55-
Q03 2018--0.71-
Q04 2017--3.20-
Q04 2016--0.19-
Q03 2016--0.16-
Q02 2016-0.14-0.18-28.57
Q01 2016-0.07-0.11-57.14
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.3377.55Positive
9/2019 QR-0.1887.41Positive
12/2019 FY-1.70--
12/2020 FY-1.53--
Next Report Date14th Aug 2019
Estimated EPS Next Report-0.33
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume110 856
Shares Outstanding (in ths.)6 866
Trades Count399
Dollar Volume181 659
Avg. Volume886 571
Avg. Weekly Volume91 492
Avg. Monthly Volume146 598
Avg. Quarterly Volume239 206
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a United States based clinical-stage biopharmaceutical company. It is focused on the development of novel next-generation cancer therapeutics. The company's product candidate is apatorsen which is designed to block the production of heat shock protein 27, or Hsp27, a protein that promotes treatment resistance in cancer. The group has business offices located in Bothell, Washington and Vancouver, British Columbia.

CEO: Richard Alistair Balfour Stewart

Teplephone: +1 604) 210-2217

Address: 1040 West Georgia Street, Bothell V6E 4H1, WA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

45%55%

Bearish Bullish

68%32%

Bearish Bullish

47%53%

News